Brief: AI-Driven Genomics Platform OmnigenicsAI To Go Public Via $340 Mln De-SPAC Transaction

APx Acquisition I

26/03/2024 12:33

March 26 (Reuters) - APx Acquisition Corp. I,
OmnigenicsAI Corp and MultiplAI Health Ltd:
    * APX ACQUISITION CORP. I, OMNIGENICSAI CORP AND MULTIPLAI
HEALTH
LTD ENTER INTO BUSINESS COMBINATION AGREEMENT TO CREATE A GLOBAL
AI-DRIVEN GENOMICS PLATFORM
    * APX ACQUISITION CORP I: UPON CLOSING, OMNIGENICSAI'S
SHARES ARE
EXPECTED TO BE LISTED ON NASDAQ UNDER TICKER SYMBOL "OMNI"
    * APX ACQUISITION CORP I - DEAL VALUES OMNIGENICSAI AND
MULTIPLAI
AT A COMBINED ENTERPRISE VALUE OF APPROXIMATELY $340 MILLION AT
SIGNING
    * APX ACQUISITION CORP I - UPON CLOSING OF DEAL,
OMNIGENICSAI WILL
BECOME A PUBLICLY LISTED COMPANY

Source text for Eikon:  ID:nPn6jt94Ca 
Further company coverage:  APXI.O 

 ((Reuters.Briefs@thomsonreuters.com;))